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To investigate whether the diagnostic performance of lesion-to-fat elasticity ratio (Eratio) was
affected by the location of the reference fat.
Methods
For 257 breast masses in 250 women who underwent shear-wave elastography before
biopsy or surgery, multiple Eratios were measured with a fixed region-of-interest (ROI) in the
mass along with multiple ROIs over the surrounding fat in different locations. Logistic
regression analysis was used to determine that Eratio was independently associated with
malignancy adjusted for the location of fat ROI (depth, laterality, and distance from lesion or
skin). Mean (Emean) and maximum (Emax) elasticity values of fat were divided into four
groups according to their interquartile ranges. Diagnostic performance of each group was
evaluated using the area under the ROC curve (AUC). False diagnoses of Eratio were
reviewed for ROIs on areas showing artifactual high or low stiffness and analyzed by logistic
regression analysis to determine variables (associated palpable abnormality, lesion size,
the vertical distance from fat ROI to skin, and elasticity values of lesion or fat) independently
associated with false results.
Results
Eratio was independently associated with malignancy adjusted for the location of fat ROI
(P<0.0001). Among four groups of fat elasticity values, the AUC showed no significant dif-
ference (<25th percentile, 25th percentile~median, median~75th percentile, and75th per-
centile; 0.973, 0.982, 0.967, and 0.954 for Emean; 0.977, 0.967, 0.966, and 0.957 for Emax).
Fat elasticity values were independently associated with false results of Eratio with the cut-
off of 3.18 from ROC curve (P<0.0001). ROIs were set on fat showing artifactual high
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stiffness in 90% of 10 false negatives and on lesion showing vertical striped artifact or fat
showing artifactual low stiffness in 77.5% of 71 false positives.
Conclusion
Eratio shows good diagnostic performance regardless of the location of reference fat, except
when it is placed in areas of artifacts.
Introduction
Breast elastography as a method of imaging tissue stiffness has been used to improve diagnostic
confidence and increase the specificity of ultrasound interpretation. The recently developed
shear-wave elastography (SWE) uses the acoustic radiation force induced by the ultrasound
push pulse generated by the ultrasound transducer [1]. This force induces mechanical waves,
including shear waves, which propagate transversely in the tissue. The SWE allows measure-
ment of the propagation speed of shear waves within the tissue to locally quantify its stiffness
in kilopascals (kPa). Within a given region of interest (ROI), a variety of stiffness parameters
can be measured, including the mean stiffness (Emean), maximum stiffness (Emax), and standard
deviation [2].
In addition, SWE can provide the elasticity ratio (Eratio) of the breast lesion to the reference
fat tissue, similar to the strain ratio obtained from strain elastography technique. In previous
studies, the diagnostic performance of Eratio has been as good as that of Emean or Emax [3–5], or
even the highest among SWE parameters [6–8]. In measuring Eratio, however, there has been
no precise information about the location of ROI for the reference fat, although elasticity values
of breast mass such as Emean and Emax are supposed to be measured over the stiffest part of the
lesion including the immediate adjacent stiff tissue or halo. Considering the ultrasonographic
breast anatomy that the layers of subcutaneous and retromammary fat are over and beneath
the fibroglandular tissue, respectively, and intervened with the fibroglandular tissue, the ROI
for the reference can be set on various locations in measuring Eratio. For strain elastography,
previous studies reported that changing the position of the reference area influenced the strain
ratio measurements [9,10]. However, there has been no study of the position of the reference
when measuring Eratio for breast mass at SWE.
Therefore, this study was performed to investigate whether the diagnostic performance of
Eratio was affected by the location of ROI in the reference fat.
Materials and Methods
The present retrospective study was conducted with institutional review board approval of
Gangnam Severance Hospital and a waiver of patient informed consent from the participants.
All patient records/information was anonymized and de-identified prior to analysis.
Between February 2013 and August 2013, 363 consecutive women who had been scheduled
to undergo ultrasound-guided core needle biopsy or surgical excision for breast masses were
examined by SWE. Among these patients, 257 breast masses in 250 women aged 22–90 years
(mean, 47.1 ± 11.1 years) were enrolled in the current study. The remaining 113 women were
excluded from the present study because multiple quantitative Eratios measured for the breast
mass were not available.
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Ultrasound Examinations
Breast ultrasound examinations were performed using the Aixplorer ultrasound system
(SuperSonic Imagine, Aix-en-Provence, France), which was equipped with a 4–15-MHz linear-
array transducer, by one of four radiologists with 5–10 years of experience in breast ultrasound.
The investigators knew the clinical examination and mammography results at the time of the
ultrasound examination. After obtaining gray-scale ultrasound, SWE images were obtained for
the breast masses that were scheduled to be biopsied or excised surgically. The built-in region-
of-interest (ROI) (Q-box; SuperSonic Imagine) of the system was set to include the lesion and
surrounding normal tissue, which demonstrated that a semitransparent color map of tissue
stiffness overlaid the gray-scale image with a range from dark blue, indicating the lowest stiff-
ness up to red, indicating the highest stiffness (0–180 kPa). Areas of black on the SWE images
represented tissue in which no shear wave was detected. Fixed 2 x 2-mm ROIs were placed by
an investigator over the stiffest part of the lesion, including immediate adjacent stiff tissue or
halo. A second ROI of the same size was placed in the breast fatty tissue. This allowed calcula-
tion of the ratio between the mean elasticity values in the lesion and in the fat, Eratio, by the
ultrasound system. At a single SWE image obtained from each mass, at least two quantitative
Eratios were measured with a fixed ROI for the mass along with ROIs for the surrounding fat
that were set randomly in different locations during the SWE examination (Fig 1). The system
calculated automatically Emax and Emean in kPa as well as Eratio for the mass.
Image Evaluation and Data Analysis
For each SWE image, the location of each ROI for the fat was evaluated on a Picture Archiving
and Communication System as follows: depth (superficial, deep, or equal to the center of the
lesion ROI), laterality (right, left, or center to the lesion ROI), the actual or vertical distance
from the center of lesion to the fat ROI (mm), the actual or vertical distance from the lesion
ROI to the fat ROI (mm), and the vertical distance from the fat ROI to skin (mm) (Fig 1).
The patients’ medical records were reviewed and data on the lesion size and the associated
palpable abnormality were compiled. With random effect model, the mean of Eratio was com-
pared between benign and malignant masses. Logistic regression analysis with random effect
was used to determine that Eratio was independently associated with breast cancers adjusted for
the location of ROI for the fat (depth, laterality, the actual or vertical distance from lesion, the
actual or vertical distance from the ROI of lesion, and the vertical distance from skin). Quanti-
tative Emean and Emax of the reference fat were divided into four groups according to their inter-
quartile range (< 25th percentile, 25th percentile ~ median, median ~ 75th percentile,
and 75th percentile). Diagnostic performance of Eratio in each group was evaluated and com-
pared using the area under the receiver operating characteristic (ROC) curve (AUC) by the
DeLong method [11] to determine whether the diagnostic performance of Eratio was different
according to Emean and Emax of the reference fat. False negative or false positive results accord-
ing to the optimal cut-off value for Eratio calculated from ROC curve were analyzed by logistic
regression analysis with random effect to determine variables (the associated palpable abnor-
mality, lesion size, the vertical distance from fat ROI to skin, and elasticity values of lesion or
fat) independently associated with false results of Eratio. SWE images of false results were
reviewed by four radiologists in consensus to determine whether ROIs were set on lesion or fat
tissue showing artifactual high or low stiffness.
Statistical analysis was performed using statistical software programs (SAS, version 9.2, SAS
Institute Inc., Cary, NC, USA). Differences were considered to be statistically significant for a P
value less than 0.05.
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Results
Of the 257 masses, 122 (47.5%) were malignant and 135 (52.5%) were benign. Lesion size
defined as the maximal diameter at ultrasound ranged from 3 to 38 mm (mean, 14.5 ± 8.2
mm). The mean lesion size of benign masses was 11.9 mm (range, 3–35 mm) and that of malig-
nant masses was 17.6 mm (range, 4–38 mm). 71 masses (27.6%) were palpable. On per-case
Fig 1. Images of invasive ductal carcinoma in a 54-year-old woman. (A-C) At a single SWE image obtained from the mass, four Eratios are measured with
a fixed ROI for the mass (white arrow) along with four ROIs for the surrounding fat that are set randomly in different four locations (white arrowheads). (A, left)
The actual (orange double-headed solid arrow) or vertical (orange double-headed dotted arrow) distance from the center of lesion to the fat ROI, the actual
(yellow double-headed solid arrow) or vertical (yellow double-headed dotted arrow) distance from the lesion ROI to the fat ROI, and the vertical distance from
the fat ROI to skin (blue double-headed solid arrow) was measured on gray-scale image. (C) For the ROI that is set on the fat tissue showing artifactual
vertical light blue color stiffness at SWE (Emean, 39.0 kPa; Emax, 46.9 kPa) (white arrowhead), Eratio was 2.73 which was false negative result according to the
cutoff value of 3.18.
doi:10.1371/journal.pone.0138074.g001
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basis, the number of Eratio measured for each breast mass ranged from two to seven (mean, 4.3)
and there was 1,109 Eratio measurements after including all the measurements for each lesion.
The mean of Eratio was significantly different between benign (2.33 ± 1.84) and malignant mas-
ses (8.39 ± 5.51) (P< 0.0001). For the diagnosis of malignant breast mass, the odds ratio of Era-
tio was 1.988 (95% confidence interval (CI), 1.715 to 2.305). In the ROC curve analysis, the
AUC of Eratio was 0.926 (95% CI, 0.911 to 0.941) with the optimal cut-off value of 3.18 (sensi-
tivity, 91.5%; specificity, 79.9%). The optimal cut-off value of lesion Emean and Emax was 59.8
kPa (95% CI, 55.7 to 80.6) and 78.2 kPa (95% CI, 72.9 to 108.6), respectively.
For the location of fat ROI in 1,109 cases of Eratio, the depth of fat ROI was equal in 185
cases (16.7%), superficial in 893 cases (80.5%), and deep in 31 cases (2.8%) to lesion ROI. The
laterality of fat ROI was center in 123 cases (11.1%), right in 426 cases (38.4%), and left in 560
cases (50.5%) to lesion ROI. The means were 11.9 mm of the actual distance from lesion center
(range, 1.2–25.8 mm), 9.0 mm of the vertical distance from lesion center (range, 0.3–24.3 mm),
10.8 mm of the actual distance from lesion ROI (range, 2.6–23.9 mm), 8.9 mm of the vertical
distance from lesion ROI (range, 0.2–22.3 mm), and 5.6 mm of the vertical distance from skin
(range, 1.1–23.2 mm). At logistic regression analysis, higher Eratio was independently associated
with breast cancer adjusted for the location of ROI in fat (depth, laterality, the actual or vertical
distance from the lesion, the actual or vertical distance from the ROI of lesion, and the vertical
distance from skin) (P< 0.0001). The AUC of Eratio was not changed according to the location
of ROI in the fat (Table 1).
Regarding the elasticity values of the reference fat, the 25th percentile, median, and 75th
percentile of elasticity values of the reference fat were 11.5 kPa, 16.9 kPa, and 25.3 kPa for
Emean (range, 1.7–59.9 kPa) and 16.3 kPa, 24.7 kPa, and 35.7 kPa for Emax (range, 2.6–95.2
kPa), respectively. There was no significant difference in the AUC of Eratio according to the
interquartile range of the elasticity values of the reference fat (Table 2).
Among 1,109 cases of Eratio, 110 (9.9%) were false positive and 48 (4.3%) were false negative
according to the cut-off value of 3.18 from ROC curve. On per-lesion basis, Eratios obtained
from a single mass were all true in 160 masses, all false negative in one mass, and all false posi-
tive in one mass. In the remaining 95 masses, both true and false results (false positive in 66
and false negative in 29) were obtained from the same mass with the different fat ROI. Table 3
provides the variables independently associated with false positive or false negative results of
Eratio. For false positive results, the odds significantly increased with associated palpable abnor-
mality (P = 0.0004) and higher elasticity values of lesion and significantly decreased with higher
elasticity values of fat (P< 0.0001). For false negative results, the odds significantly increased
with higher elasticity values of fat (P< 0.0001) and significantly decreased with associated pal-
pable abnormality (P = 0.027), and higher elasticity values of lesion (P< 0.0001). For Emean
and Emax of fat, 10 false negative cases and 71 false positive cases were found after adjusting
associated palpable abnormality, with the cut-off values of 59.8 kPa in lesion Emean and 78.2
kPa in lesion Emax. After reviewing SWE images of those 81 false cases for artifacts, ROIs were
set on fat tissue showing artifactual high stiffness in nine (90%) of 10 false negative cases (Fig
1) and on lesion showing vertical striped artifact (n = 48; 67.6%) (Fig 2) or fat tissue showing
artifactual low stiffness (n = 7; 9.9%) (Fig 3) in 55 (77.5%) of 71 false positive cases.
Discussion
In the present study, we analyzed the diagnostic performance of Eratio at SWE according to the
different location of ROI in fat (depth, laterality, the distance from the lesion, and the distance
from skin). We discovered that the diagnostic performance of Eratio was not influenced by the
measurement site of fat elasticity and the odds of breast cancer significantly increased with
Reference Fat Location for Lesion-Fat Elasticity Ratio
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higher Eratio, regardless of the location of ROI in fat (Table 1). Although there is no report of
Eratio at SWE according the location of the reference fat, a few studies have reported the rela-
tionship between the lesion depth and the lesion stiffness. In a phantom study of tissue quanti-
fication using acoustic radiation force impulse technology from another ultrasound system of
SWE, shear wave velocity measured at varying depths of the target regions showed the
Table 1. Diagnostic performance of Eratio for characterization of breast masses, adjusted for location of fat ROI.
Model Variable Odds ratio (95% CI) P value AUC
Eratio Eratio 1.988 (1.715, 2.305) < 0.0001 0.926
+ Depth* Eratio 1.942 (1.671, 2.257) < 0.0001 0.927
Equal vs Superﬁcial 0.448 (0.167, 1.197) 0.109
Equal vs Deep 0.921 (0.074, 11.504) 0.949
+ Laterality* Eratio 2.010 (1.729, 2.337) < 0.0001 0.926
Center vs Right 0.692 (0.248, 1.931) 0.482
Center vs Left 0.918 (0.338, 2.492) 0.866
+ Actual distance from lesion center Eratio 1.969 (1.695, 2.288) < 0.0001 0.926
Distance (mm) 1.031 (0.947, 1.123) 0.476
+ Vertical distance from lesion center Eratio 1.989 (1.709, 2.314) < 0.0001 0.926
Distance (mm) 0.999 (0.932, 1.072) 0.988
+ Actual distance from lesion ROI Eratio 1.997 (1.720, 2.318) < 0.0001 0.926
Distance (mm) 0.979 (0.906, 1.057) 0.584
+ Vertical distance from lesion ROI Eratio 1.985 (1.708, 2.307) < 0.0001 0.926
Distance (mm) 1.004 (0.938, 1.074) 0.913
+ Vertical distance from skin Eratio 1.994 (1.718, 2.314) < 0.0001 0.927
Distance (mm) 0.957 (0.823, 1.113) 0.569
AUC = the area under the receiver operating characteristic curve, CI = Conﬁdence interval, Eratio = elasticity ratio, the ratio between the mean elasticity
values in the lesion and in the fatty tissue, ROI = Region of interest
* Relative location of the ROI for fat to the ROI for lesion
doi:10.1371/journal.pone.0138074.t001
Table 2. Diagnostic performance of Eratio according to the interquartile range of elasticity value of the fat.
Fat elasticity value IQR AUC of Eratio (95% CI) Comparison of AUC of Eratio P value
Emean < 25
th percentile 0.973 (0.954, 0.991) < 25th percentile vs 25th percentile ~ median 0.415
25th percentile ~ median 0.982 (0.969, 0.996) < 25th percentile vs Median ~ 75th percentile 0.694
Median ~ 75th percentile 0.966 (0.942, 0.991) < 25th percentile vs  75th percentile 0.283
 75th percentile 0.954 (0.926, 0.982) 25th percentile ~ median vs Median ~ 75th percentile 0.267
25th percentile ~ median vs  75th percentile 0.077
Median ~ 75th percentile vs  75th percentile 0.436
Emax < 25
th percentile 0.977 (0.961, 0.992) < 25th percentile vs 25th percentile ~ median 0.462
25th percentile ~ median 0.967 (0.947, 0.987) < 25th percentile vs Median ~ 75th percentile 0.449
Median ~ 75th percentile 0.966 (0.942, 0.989) < 25th percentile vs  75th percentile 0.196
 75th percentile 0.957 (0.930, 0.983) 25th percentile ~ median vs Median ~ 75th percentile 0.925
25th percentile ~ median vs  75th percentile 0.531
Median ~ 75th percentile vs  75th percentile 0.591
IQR = Interquartile range, AUC = the area under the receiver operating characteristic curve, CI = Conﬁdence interval, Emean = mean elasticity value of the
reference fat, Emax = maximum elasticity value of the reference fat, Eratio = elasticity ratio, the ratio between the mean elasticity values in the lesion and in
the fatty tissue
doi:10.1371/journal.pone.0138074.t002
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increasing dispersion of the values for the deep target regions [12]. Similarly, a study of SWE
with 939 breast masses using the prototype ultrasound system of SWE reported that there was
a 4.5-kPa decrease in lesion stiffness for each 5-mm increase in lesion depth (P = 0.01), on aver-
age, across all masses [3]. At SWE, the ultrasound push pulse generated by the ultrasound
transducer is attenuated as it traverses tissue, which can result in a reduction of the amplitude
of shear waves generated in the deeper lesion [13]. In the present study, the diagnostic perfor-
mance of Eratio was evaluate according to the location of the fat ROI, unlike those previous
studies that evaluated the lesion elasticity values according to the lesion depth from the skin,
which could explain the discrepancy in results. Interestingly, a previous study reported that the
discriminating ability of Eratio in malignancy was not influenced by the lesion depth from skin
[8]. Further evaluation may be necessary to find out how the discriminating ability of Eratio in
malignancy was not influenced by the depth from the lesion or the reference fat to skin.
For Eratio at SWE, the elasticity value of the reference fat can be as important as the lesion
stiffness is, rather than the location of the fat ROI itself, because the fat stiffness is the denomi-
nator in calculating Eratio of the lesion arithmetically. Even small difference in fat stiffness
could be expected to make a difference in Eratio significant. In the present study, Emean and
Emax of the reference fat showed wide variability, ranging from 1.7 to 59.9 kPa and from 2.6 to
95.2 kPa, respectively, which was attributable to fat ROIs that were set randomly. However, the
25th percentile, median, and 75th percentile of elasticity values of the reference fat except for
the 75th percentile of Emax (35.7 kPa) were around the range of reported normal fat values (18
to 24 kPa) in the literature [14]. Moreover, all groups of Emean and Emax of the reference fat
according to their interquartile range showed good diagnostic performance of Eratio with AUC
ranging from 0.954 to 0.982. Although the group of 75th percentile or more showed the lowest
AUC, the diagnostic performance of Eratio was not significantly different among the groups
(Table 2).
Table 3. Logistic regression analysis of variables independently associated with false positive or
negative results of Eratio.
Eratio Variable Odds ratio (95% CI) P value
False positive Palpability 3.167 (1.679, 5.975) 0.0004
Lesion size (mm) 1.025 (0.993, 1.059) 0.127
Distance from skin (mm) 1.028 (0.918, 1.150) 0.633
Lesion Emean (kPa) 1.059 (1.044, 1.075) <0.0001
Lesion Emax (kPa) 1.045 (1.033, 1.057) <0.0001
Fat Emean (kPa) 0.849 (0.813, 0.886) <0.0001
Fat Emax (kPa) 0.857 (0.827, 0.889) <0.0001
False negative Palpability 0.360 (0.145, 0.889) 0.027
Lesion size (mm) 0.946 (0.904, 1.091) 0.059
Distance from skin (mm) 0.876 (0.734, 1.045) 0.141
Lesion Emean (kPa) 0.967 (0.958, 0.975) <0.0001
Lesion Emax (kPa) 0.972 (0.965, 0.979) <0.0001
Fat Emean (kPa) 1.134 (1.097, 1.173) <0.0001
Fat Emax (kPa) 1.091 (1.063, 1.120) <0.0001
Eratio = elasticity ratio, the ratio between the mean elasticity values in the lesion and in the fatty tissue,
CI = Conﬁdence interval, Emean = mean elasticity value, Emax = maximum elasticity value, Distance from
skin = vertical distance from skin to ROI for the fat
doi:10.1371/journal.pone.0138074.t003
Reference Fat Location for Lesion-Fat Elasticity Ratio
PLOS ONE | DOI:10.1371/journal.pone.0138074 September 14, 2015 7 / 11
The results of the current study showed a good diagnostic performance of Eratio, regardless
of the location of fat ROI and the elasticity values measured in fat. However, false negative or
positive results of Eratio still remain as a pitfall in the diagnosis of breast cancer. We found 95
masses (37%, of 257) showing both true and false results (false positive in 66 and false nega-
tive in 29) according to the different fat ROI, which were reviewed and analyzed to determine
associated features. During the time of obtaining SWE images, artifactual high or low strain
Fig 2. Images of fibrocystic change in a 43-year-old woman. For the ROI that is set on the lesion showing the vertical stripe pattern of artifacts (arrows) at
SWE (Emean, 48.5 kPa; Emax, 55.3 kPa), Eratios were 3.77 and 7.68 measured with two different fat ROIs (arrowheads) which were false positive results
according to the cutoff value of 3.18.
doi:10.1371/journal.pone.0138074.g002
Fig 3. Images of fibroadenoma in a 42-year-old woman. For the ROI that is set on the fat tissue showing black color at SWE (Emean, 3.6 kPa; Emax, 11.3
kPa) (arrows), Eratio was 5.87 which was false positive result according to the cutoff value of 3.18.
doi:10.1371/journal.pone.0138074.g003
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can be seen in the surrounding fat tissue by factors affecting data quality and producing
speed errors or loss of signal [15]. For example, continuous high strain without connection to
the strain from the mass can be shown at the surrounding tissue, or discontinuous high strain
can be located at the superficial or deep portion of the ROI box. In a study, SWE images
showing such artifactual stiffness were approximately 15.3% [16]. In contrast, some areas
with low ultrasonic echo signal in the ROI box can be coded as very dark blue or black color
with or without low echo signal at corresponding grey-scale image (Fig 3). As SWE feature of
breast lesion, area of black color inside the lesion without elasticity information is well
known as black hole phenomenon. It appears as the shear wave cannot propagate into the
hard lesion such as malignancy or into liquid areas such as cyst [2,17–19]. For breast fat tis-
sue, such artifactual low stiffness has not been discussed in literatures. Yet, we found seven
cases of ROIs set on fat tissue showing artifactual low stiffness (9.9%) among 71 false positive
cases. Although we have not found a clear explanation for this finding, factors of shear-wave
scattering or mechanical disturbance at tissue boundaries are presumed to reduce or prevent
shear-wave penetration in fatty tissue [15]. The artifactual high or low strain in the fat tissue
can give us inaccurate elasticity information in Eratio. In our study, ROIs were set on fat tissue
showing the artifactual high stiffness in 90% of false negative cases and on fat tissue showing
the artifactual low stiffness in 9.9% of false positive cases. In multivariate analysis, the odds
for false negative results increased with higher elasticity values of fat (P < 0.0001) and the
odds for false positive results decreased with higher elasticity values of fat (P< 0.0001). In
addition, for lesion elasticity value in Eratio, 67.6% of false positive cases were observed in
lesions showing vertical striped artifact where lesion ROI was set. Multivariate analysis
showed that the odds for false positive results increased with higher elasticity values of lesion
(P < 0.0001) (Fig 3). In previous studies, the vertical striped artifact was reported from 13.7%
to 30.3% and could be one of causes for erroneous interpretation [4,8,17,20,21]. This artifact
is unintentional artifactual vertical bands of stiffness that is observed at the margin or in the
interior of the lesion, extends beyond the lesion, and continues vertically in cords on the cuta-
neous side or the thoracic wall side [17]. These distinctive elastographic features could help
identify and avert areas of artifactual high stiffness from setting ROI. It is recommended that
compression or movement of the probe be minimized for SWE using generous amounts of
contact jelly, the range of Q-box be adjusted to exclude the skin and chest wall layers, and
having the patient hold her breath be effective in some cases to reduce artifacts [2]. To avoid
false positive or negative results in Eratio, therefore, images with good quality should be
obtained and ROIs for the lesion and the surrounding fat should be set on the area without
artifacts.
The present study has some limitations. Owing to its retrospective nature, there might have
been selection bias because patients included in the study were scheduled for biopsy or surgery
of known breast lesions, and it was not possible to control the consistent positioning of the fat
ROI. For large breast mass, setting multiple ROIs in the surrounding fat tissue might be limited
when the mass was big enough to occupy considerable portion of the Q-box for SWE. SWE
was performed by one of four radiologists and the interobserver variability could be a limita-
tion. Considering the prior result showing that SWE was highly reproducible for assessing the
elastographic features of breast lesions, interobserver variability was expected to have little
influence on our result [22].
In conclusion, Eratio shows good diagnostic performance regardless of the location of refer-
ence fat, except when it is placed in areas of artifacts. To avoid false diagnosis in Eratio, fat ROI
should be set on the area without artifactual high or low stiffness.
Reference Fat Location for Lesion-Fat Elasticity Ratio
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